Mingyao Liu

The Pharmacology of CAR T Cell Therapy for Autoimmune Disease

For decades, autoimmune disease treatment depended on long-term immunosuppression, which seldom yields lasting immune tolerance and carries cumulative toxic risks. Recent cell therapies, including chimeric antigen receptor (CAR) T cells, regulatory T cells, and mesenchymal stroma...